Dr.Sai Sree Reddy

Stage 4 pancreatic cancer treatment centers on combination chemotherapy (FOLFIRINOX, gemcitabine/nab-paclitaxel), single-agent regimens, targeted therapies for actionable mutations, and thorough palliative care, selected primarily by performance status (ECOG 0-1 vs. 2 vs. 3-4) and treatment goals (life extension vs. Quality of life). Key Takeaways FOLFIRINOX and gemcitabine/nab-paclitaxel serve as first-line chemotherapy options, selected by ECOG performance status, age, and organ function...

Mouth cancer treatment in India ranges from ₹2.5 to ₹12 lakhs depending on disease stage, treatment complexity, and facility selection, creating financial barriers that often delay care and worsen outcomes for thousands of patients annually. TL;DR Mouth cancer treatment costs can be reduced by 50-70% through strategic facility selection, government schemes, and transparent pricing models without compromising clinical outcomes Generic cancer medications cost 80% less than branded drugs once...

Breast cancer treatment in India ranges from ₹90,000 to ₹4,00,000 depending on disease stage and treatment modalities, creating significant financial burden for families across socioeconomic levels [1]. TL;DR Government schemes like Ayushman Bharat PM-JAY provide up to ₹5 lakh coverage for breast cancer treatment at empanelled hospitals across India [5] Generic and biosimilar breast cancer drugs through Jan Aushadhi stores cost 60-85% less than branded alternatives, with trastuzumab prices...